Skip to main content

Noor Biotech opts to establish location in Basel

Nuha Alakhmimi Noor Biotech
| News

Noor Biotech opts to establish location in Basel


Noor Biotech has established a presence in Basel. The startup, which is managed by its Saudi Arabian co-founder Nuha Alakhmimi, is developing a biosensor technology platform for the rapid, cost-effective detection of inflammatory diseases.

Nuha Alakhmimi Noor Biotech
Nuha Alakhmimi, co-founder of Noor Biotech (image: Noor Biotech)

Noor Biotech has established a presence in Basel. The recently founded startup is focusing on the development of a biosensor platform that is intended to be used for efficient, reliable and cost-effective detection of inflammatory diseases at an early stage. In turn, this should help to ensure prompt and targeted treatment approaches. According to the company, later plans will focus on expanding the platform to cover other diseases and health conditions.

In Basel, the company will continue its development work and is striving to commercialize its platform during the course of this year. Over the longer term, the plan is to employ 10 to 40 staff. The investment and innovation promotion agency Basel Area Business & Innovation supported Noor Biotech in establishing its presence in Basel.

Positive economic framework in Basel

Noor Biotech is headed up by co-founder Nuha Alakhmimi, who studied biomedical sciences and cellular biology at Alfaisal University in the Saudi Arabian capital of Riyadh. Thereafter, she obtained a PhD from Friedrich Schiller University Jena in Germany.

Positive economic framework conditions in Basel were a significant pull factor behind Noor Biotech establishing a business presence in the region, the company explains. Other key factors included the science cluster and the laboratory infrastructure on offer, in addition to proximity to potential partners and customers.

Biosensor technologies are becoming increasingly vital for progress in the healthcare sector. Non-invasive, low-cost, high-resolution and portable biosensors can be used on a large scale. A biosensor detects a specific biological analyte and monitors its function within a biological environment.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.